BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7565136)

  • 1. Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice.
    Herrera MA; de Plata C; González JM; Corradin G; Herrera S
    Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():71-6. PubMed ID: 7565136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
    Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
    Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of synthetic peptide constructs based on PvMSP9
    Rodrigues-da-Silva RN; Correa-Moreira D; Soares IF; de-Luca PM; Totino PRR; Morgado FN; Oliveira Henriques MDG; Peixoto Candea AL; Singh B; Galinski MR; Moreno A; Oliveira-Ferreira J; Lima-Junior JDC
    Vaccine; 2019 Jan; 37(2):306-313. PubMed ID: 30509693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
    Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
    Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
    Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
    Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoites.
    Bilsborough J; Baumgart K; Bathurst I; Barr P; Good MF
    Acta Trop; 1997 May; 65(2):59-80. PubMed ID: 9164601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.
    Caro-Aguilar I; Lapp S; Pohl J; Galinski MR; Moreno A
    Microbes Infect; 2005 Oct; 7(13):1324-37. PubMed ID: 16253535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
    Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
    Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.
    Herrera S; Escobar P; de Plata C; Avila GI; Corradin G; Herrera MA
    J Immunol; 1992 Jun; 148(12):3986-90. PubMed ID: 1376347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
    Rosa DS; Iwai LK; Tzelepis F; Bargieri DY; Medeiros MA; Soares IS; Sidney J; Sette A; Kalil J; Mello LE; Cunha-Neto E; Rodrigues MM
    Microbes Infect; 2006 Jul; 8(8):2130-7. PubMed ID: 16797207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the humoral response to repeat and non-repeat sequences of the circumsporozoite protein of Plasmodium vivax using novel adjuvant and delivery systems.
    Thomas BE; Manocha M; Haq W; Adak T; Pillai CR; Rao DN
    Ann Trop Med Parasitol; 2001 Jul; 95(5):451-72. PubMed ID: 11487368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
    Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
    Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
    Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
    Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.
    Romero PJ; Tam JP; Schlesinger D; Clavijo P; Gibson H; Barr PJ; Nussenzweig RS; Nussenzweig V; Zavala F
    Eur J Immunol; 1988 Dec; 18(12):1951-7. PubMed ID: 2464495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein.
    Munesinghe DY; Clavijo P; Calle MC; Nussenzweig RS; Nardin E
    Eur J Immunol; 1991 Dec; 21(12):3015-20. PubMed ID: 1721025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.